Records the radiation treatment-boost modality used to deliver the most clinically significant dose to the primary volume of interest during the first course of treatment. This is accomplished with external beam fields of reduced size (relative to the regional treatment fields), implants, stereotactic radiosurgery, conformal therapy, or intensity-modulated radiation therapy. External beam boosts may consist of two or more successive phases with progressively smaller fields, and they are generally coded as a single entity. This field is used with Rad--Regional RX Modality [1570]. Radiation treatment frequently is delivered in two or more phases that can be summarized as regional and boost treatments. For outcomes analysis, the modalities used for each of these phases can be very important... NAACCR Data Standards and Data Dictionary Version 11
status
ACTIVE
Fully-Specified Name
component
Boost radiation treatment modality
property
Prid = Presence or identity: Prid stands for “Presence or identity”, is used for assays that detect whether or not an analyte of a particular kind is present, and if it is, to identify the specific analyte.
time
Pt = Point in time: To identify measures at a point in time. This is a synonym for “spot” or “random” as applied to urine measurements.
system
Radiation.Rx
scale
Nom = Nominal: Nominal or categorical responses that do not have a natural ordering. (e.g., names of bacteria, reported as answers, categories of appearance that do not have a natural ordering, such as, yellow, clear, bloody.
method
Additional Names
short name
Boost radiation Tx modality; Identity or presence; Nominal; Oncology; Point in time; Rad; Radiation Rx; Random; Treatment; TUMOR REGISTRY(NAACCR); Tx